Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.29B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$937M |
| 3 |
iShares Floating Rate Bond ETF
FLOT
|
+$662M |
| 4 |
iShares MSCI United Kingdom ETF
EWU
|
+$615M |
| 5 |
iShares MSCI EAFE Value ETF
EFV
|
+$541M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$1.06B |
| 2 |
Vanguard Total International Stock ETF
VXUS
|
+$717M |
| 3 |
Vanguard Total International Bond ETF
BNDX
|
+$633M |
| 4 |
SPDR Gold Trust
GLD
|
+$617M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$512M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.47% |
| 2 | Consumer Discretionary | 2.1% |
| 3 | Financials | 1.38% |
| 4 | Communication Services | 1.28% |
| 5 | Healthcare | 1.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZTR
8101
Virtus Total Return Fund
ZTR
$338M
| $84.2K | ﹤0.01% |
+13,000
| New | +$85.6K |
|
|
NVTA
8102
PUT
DELISTED
Invitae Corporation
NVTA
| $83.7K | ﹤0.01% |
62,000
-434,900
| -88% | -$857K |
|
8103
Spruce Power Holding Corp
SPRU
$38.4M
| $83.6K | ﹤0.01% |
12,741
-25,797
| -67% | -$221K |
|
|
IPM
8104
Intelligent Protection Management Corp
IPM
$25M
| $83.5K | ﹤0.01% |
+39,207
| New | +$98.4K |
|
8105
DHI Group
DHX
$166M
| $83.4K | ﹤0.01% |
21,483
+1,422
| +7% | +$6.75K |
|
8106
Protalix BioTherapeutics
PLX
$196M
| $83.3K | ﹤0.01% |
39,665
-52,554
| -57% | -$92.2K |
|
8107
eGain
EGAN
$203M
| $83K | ﹤0.01% |
+10,933
| New | +$94K |
|
|
SLGC
8108
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $82.8K | ﹤0.01% |
32,453
+16,878
| +108% | +$48.4K |
|
8109
PUT
Allogene Therapeutics
ALLO
$732M
| $82.5K | ﹤0.01% |
+16,700
| New | +$107K |
|
8110
CALL
GrafTech
EAF
$206M
| $82.1K | ﹤0.01% |
+1,690
| New | +$91.5K |
|
|
MSPRZ
8111
DELISTED
MSP Recovery Inc Warrant
MSPRZ
| $81.5K | ﹤0.01% |
91,572
| – | – |
|
8112
Holley
HLLY
$378M
| $81.5K | ﹤0.01% |
29,730
+1,898
| +7% | +$4.85K |
|
|
BGRY
8113
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
| $81K | ﹤0.01% |
58,680
+39,105
| +200% | +$46.5K |
|
|
HIX
8114
Western Asset High Income Fund II
HIX
$355M
| $80.9K | ﹤0.01% |
16,648
-2,769
| -14% | -$14.7K |
|
|
AKTS
8115
CALL
DELISTED
Akoustis Technologies Inc
AKTS
| $80.7K | ﹤0.01% |
+26,200
| New | +$91.4K |
|
8116
CALL
Summit Therapeutics
SMMT
$12.1B
| $80.5K | ﹤0.01% |
46,000
-117,400
| -72% | -$320K |
|
|
PHX
8117
DELISTED
PHX Minerals
PHX
| $80.4K | ﹤0.01% |
30,676
+9,197
| +43% | +$29.2K |
|
8118
Riverview Bancorp
RVSB
$107M
| $80.3K | ﹤0.01% |
+15,041
| New | +$102K |
|
|
CANO
8119
DELISTED
Cano Health, Inc.
CANO
| $80.3K | ﹤0.01% |
882
-2,551
| -74% | -$346K |
|
8120
MaxCyte
MXCT
$133M
| $80.2K | ﹤0.01% |
+16,195
| New | +$79.7K |
|
|
PTRA
8121
DELISTED
Proterra Inc. Common Stock
PTRA
| $80.1K | ﹤0.01% |
52,707
-41,488
| -44% | -$156K |
|
8122
SOPHiA GENETICS
SOPH
$638M
| $80K | ﹤0.01% |
+16,091
| New | +$52.1K |
|
8123
PUT
RLX Technology
RLX
$2.42B
| $79.8K | ﹤0.01% |
27,500
-839,900
| -97% | -$2.04M |
|
8124
CALL
Aspen Aerogels
ASPN
$510M
| $79.7K | ﹤0.01% |
10,700
-3,200
| -23% | -$31.8K |
|
8125
Granite Ridge Resources
GRNT
$683M
| $79.5K | ﹤0.01% |
+13,548
| New | +$91.6K |
|
Similar funds
Jane Street's Q1 2023 Portfolio in Review
As of Q1 2023, Jane Street held 10,675 positions worth $244B, up 13% from $216B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Jane Street's Q1 2023 filing shows 1,657 new, 3,180 increased, 3,974 reduced and 1,760 closed positions. Its largest new stake was iShares MSCI EAFE Value ETF: 11,182,830 shares worth $543M. The largest sale was iShares Core MSCI Emerging Markets ETF, an estimated $1.06B.
By sector, the portfolio is most concentrated in Technology at 2.5% of assets, up from 2.4% a quarter earlier, followed by Consumer Discretionary and Financials.
- Jane Street's largest Q1 2023 buy was iShares MSCI EAFE Value ETF: 11,182,830 shares worth $543M.
- Jane Street added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q1 2023, an estimated $1.29B increase.
- Jane Street's biggest Q1 2023 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $1.06B.
- Jane Street fully exited State Street SPDR Bloomberg Convertible Securities ETF in Q1 2023, selling an estimated $119M.
- Jane Street's ten largest holdings make up 36% of its $244B portfolio in Q1 2023.
- Jane Street opened 1,657 new positions and closed 1,760 in Q1 2023.
- Jane Street's portfolio value rose 13% quarter-over-quarter to $244B.
Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.